Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.51 |
| ▸ | ACHE | P22303 | 2/20 | 0.51 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.45 |
| ▸ | CTSG | P08311 | 1/20 | 0.45 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.45 |
| ▸ | CMA1 | P23946 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24924116 | 1.00 | BCHE (0.51) | BCHEACHECYP26A1SMN1; SMN2CTSL | |
| SCHEMBL21362725 | 0.88 | GAA (0.52) | CYP26A1CTSLRAB9AGAAKMT2A | |
| SCHEMBL25961771 | 0.86 | NPC1 (0.44) | BCHEACHECYP26A1SMN1; SMN2RAB9A | |
| SCHEMBL3928918 | 0.86 | HPGD (0.62) | BCHEACHECYP26A1SMN1; SMN2CTSL | |
| SCHEMBL29188972 | 0.85 | CYP26A1 (0.54) | BCHEACHECYP26A1SMN1; SMN2CTSL | |
| SCHEMBL6313152 | 0.84 | L3MBTL1 (0.61) | BCHEACHECYP26A1P2RY12MEN1 | |
| SCHEMBL3706987 | 0.84 | L3MBTL1 (0.61) | BCHEACHECYP26A1P2RY12MEN1 | |
| SCHEMBL26199837 | 0.84 | CYP26A1 (0.53) | BCHEACHECYP26A1SMN1; SMN2CTSL | |
| SCHEMBL27673425 | 0.84 | CYP26A1 (0.53) | BCHEACHECYP26A1SMN1; SMN2CTSL | |
| SCHEMBL10656249 | 0.83 | CTSL (0.49) | BCHEACHECYP26A1SMN1; SMN2CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257405-A1 | METHOD FOR PREPARING GLUFOSINATE OR ANALOGUES THEREOF | LIER CHEMICAL CO., LTD. (CN) | 2023-08-17 | — | — | US | disclosed |
| EP-4219512-A1 | METHOD FOR PREPARING GLUFOSINATE OR ANALOG THEREOF | Lier Chemical Co., Ltd. (CN) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023001132-A1 | METHOD FOR PREPARING GLUFOSINATE OR ANALOG THEREOF | 利尔化学股份有限公司 | 2023-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257405-A1 | METHOD FOR PREPARING GLUFOSINATE OR ANALOGUES THEREOF | FPGS, TYMP, GLUL | BCHE 519/4885ACHE 2208/4885CYP26A1 1339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.